Statistical review: frequently given comments updated.

IF 20.6 1区 医学 Q1 RHEUMATOLOGY Annals of the Rheumatic Diseases Pub Date : 2025-05-01 Epub Date: 2025-03-08 DOI:10.1016/j.ard.2025.02.007
Stian Lydersen
{"title":"Statistical review: frequently given comments updated.","authors":"Stian Lydersen","doi":"10.1016/j.ard.2025.02.007","DOIUrl":null,"url":null,"abstract":"<p><p>From 2006 to 2024, I have carried out statistical reviews of about 700 manuscripts for Annals of the Rheumatic Diseases and RMD open. My most frequent review comments concern the following: 1. Report how missing data were handled. 2. Limit the number of covariates in regression analyses. 3. Do not use stepwise selection of covariates. 4. Validate prediction models. 5. Adjust for baseline values in randomised controlled trials. 6. Do not adjust for baseline values in observational studies. 7. Dichotomising a continuous variable can be a bad idea. 8. Student t test is better than nonparametric tests. 9. Mean (SD) are also relevant for nonnormally distributed data. 10. Adjusting P values for multiplicity. 11. Report estimate, CI, and (possibly) P value-in that order of importance. 12. Do not test for baseline imbalances in a randomised controlled trial. 13. Format for reporting CIs. 14. Mind the number of reported decimal places. 15. Report absolute numbers where relevant.</p>","PeriodicalId":8087,"journal":{"name":"Annals of the Rheumatic Diseases","volume":" ","pages":"660-663"},"PeriodicalIF":20.6000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of the Rheumatic Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ard.2025.02.007","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/8 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

From 2006 to 2024, I have carried out statistical reviews of about 700 manuscripts for Annals of the Rheumatic Diseases and RMD open. My most frequent review comments concern the following: 1. Report how missing data were handled. 2. Limit the number of covariates in regression analyses. 3. Do not use stepwise selection of covariates. 4. Validate prediction models. 5. Adjust for baseline values in randomised controlled trials. 6. Do not adjust for baseline values in observational studies. 7. Dichotomising a continuous variable can be a bad idea. 8. Student t test is better than nonparametric tests. 9. Mean (SD) are also relevant for nonnormally distributed data. 10. Adjusting P values for multiplicity. 11. Report estimate, CI, and (possibly) P value-in that order of importance. 12. Do not test for baseline imbalances in a randomised controlled trial. 13. Format for reporting CIs. 14. Mind the number of reported decimal places. 15. Report absolute numbers where relevant.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
统计审查:经常给出更新的评论。
从2006年到2024年,我对《风湿病年鉴》和《风湿病开放》的约700篇稿件进行了统计审评。我最常见的评论如下:报告如何处理丢失的数据。2. 限制回归分析中协变量的数量。3. 不要使用逐步选择协变量。4. 验证预测模型。5. 在随机对照试验中调整基线值。6. 在观察性研究中不要调整基线值。7. 对连续变量进行二分类可能是个坏主意。8. 学生t检验优于非参数检验。9. 均值(SD)也适用于非正态分布的数据。10. 调整多重性的P值。11. 按重要性顺序报告估计、CI和(可能的)P值。12. 不要在随机对照试验中检测基线失衡。13. 报告ci的格式。14. 注意报告的小数位数。15. 在相关的地方报告绝对数字。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases 医学-风湿病学
CiteScore
35.00
自引率
9.90%
发文量
3728
审稿时长
1.4 months
期刊介绍: Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal covering all aspects of rheumatology, which includes the full spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research, including the most important recommendations for the management of various conditions.
期刊最新文献
Inhibition of the type I interferon receptor pathway protects against muscle weakness induced by dermatomyositis serum. Neutrophil transcriptomics in SLE reveals intrinsic disease signatures, shared ex vivo adaptation, and transcriptional reset after CAR T-cell therapy. Risk score for early mortality to stratify for intensive SSc therapy in the EUSTAR network: the RESIST score. Risk of first and second primary keratinocyte cancers in relation to treatment of rheumatoid arthritis with JAKi, TNFi, and non-TNFi bDMARDs-a Swedish nationwide study. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1